Ascendis Pharma A/S Reports First Quarter 2019 Financial Results
May 30, 2019 16:02 ET
|
Ascendis Pharma A/S
– Continued execution of global endocrinology rare disease programs, following validation of TransCon™ platform in phase 3 heiGHt Trial – – R&D Day on June 26 to feature endocrinology and...